Aisha’s Journey: Coping with Anxiety and PTSD

The Weedcoin Team

Finding Calm Amid the Storm

For those struggling with anxiety and PTSD, medical marijuana can offer a path to peace and healing when traditional treatments fall short. At Weedcoin, we’re sharing powerful stories through the MediWeed Hub with irie vibes to show its impact. In this article, we’ll dive into Aisha’s journey—a 32-year-old survivor of domestic violence who used medical marijuana to manage her anxiety and PTSD. Her experience highlights how cannabis, particularly CBD-heavy strains, can help restore calm—let’s explore Aisha’s story of finding relief!

Woman meditating in a lavender field holding cannabis oil with glowing cannabis leaf above her.

Aisha’s Mental Health Struggles


Aisha, a 32-year-old graphic designer, developed severe anxiety and PTSD after surviving a car accident in 2021. She experienced frequent panic attacks, rating her anxiety at 8/10, and struggled with insomnia, often reliving the trauma in nightmares. Traditional treatments like SSRIs helped minimally but caused side effects such as fatigue and nausea. Therapy provided coping tools, but Aisha still felt overwhelmed. After researching medical marijuana’s potential to reduce anxiety, she decided to explore cannabis as a natural option to manage her symptoms.


Starting with Medical Marijuana


Living in Colorado, a state with a robust medical cannabis program, Aisha consulted a doctor familiar with cannabis therapy. The doctor recommended a CBD-dominant strain, ACDC, with 20% CBD and 1% THC, to minimize psychoactive effects. Aisha started with 5 mg CBD via a tincture twice daily, gradually increasing to 10 mg as she assessed her response. For acute anxiety spikes, she used a sublingual strip with 2.5 mg CBD, which provided relief within 15 minutes. She ensured all products were lab-tested for safety and consistency.


Anxiety Reduction and Emotional Stability


Within two weeks, Aisha’s anxiety decreased to 5/10, a 37% improvement, allowing her to feel more grounded. The CBD in ACDC calmed her nervous system without causing a high, and she noticed fewer panic attacks—down from three weekly to one. Sleep improved significantly; she fell asleep faster and experienced fewer nightmares, waking up refreshed. Aisha also felt more emotionally stable, able to engage in social activities like coffee dates with friends, which she had avoided for years due to anxiety.


Navigating Side Effects and Adjustments


Aisha initially experienced mild drowsiness with her 10 mg CBD dose, which she adjusted by splitting it—5 mg in the morning and 5 mg at night—to stay alert during the day. She also faced challenges with cost, as her cannabis products cost $80/month, not covered by insurance. Aisha joined a dispensary loyalty program to save 15% on purchases. Some friends questioned her cannabis use, associating it with recreation, but she shared educational resources to explain its medical benefits, reducing their stigma.


Long-Term Benefits and Lifestyle Integration


After three months, Aisha’s anxiety stabilized at 4/10, and her panic attacks became rare—once a month at most. She experimented with other CBD-dominant strains, like Harlequin with 15% CBD, finding it similarly effective for daytime use. For evenings, she occasionally used a 1:1 strain with 5% THC and 5% CBD to enhance relaxation without overstimulation. Aisha incorporated mindfulness practices, like meditation, which paired well with cannabis to manage her PTSD, helping her process trauma more effectively over time.


Aisha’s Advice for Other Patients


Aisha recommends working with a doctor to find the right strain—CBD-dominant options like ACDC are ideal for anxiety without a high. She suggests starting with 5 mg CBD and adjusting slowly to avoid drowsiness. Using tinctures or sublingual strips offers quick, discreet relief for anxiety spikes. Aisha also encourages educating loved ones about cannabis’s medical use to build support and reduce stigma, which helped her feel more understood.


Admiring Aisha’s Journey at Weedcoin


At Weedcoin, we deeply admire Aisha’s courageous journey with anxiety and PTSD. Her determination to find relief through medical marijuana, reducing her anxiety by 37% and regaining emotional stability, showcases the transformative power of cannabis. Aisha’s story of reclaiming her life—returning to social activities and sleeping peacefully—highlights the potential for others to find natural relief. Her resilience and openness inspire us, reflecting the hope and healing cannabis can bring to those facing mental health challenges.


Practical Tips



Key Takeaways


Glowing cross-section of a human brain with highlighted hippocampus region in warm golden light
By The Weedcoin Team April 14, 2026
A University of Colorado study of 26,000 adults found cannabis users aged 40 to 77 had larger brain volumes and faster processing speeds. Plus a migraine trial.
Empty New Jersey convenience store shelf where hemp products were displayed with dust outlines
By The Weedcoin Team April 13, 2026
A systematic review of 564 fibromyalgia patients found cannabis cut pain scores from 9.0 to 5.0 in six months. NJ hemp shelves go empty today. Seven days to 420.
Texas hemp shop restocking shelves after a judge blocked the statewide smokable hemp ban
By The Weedcoin Team April 12, 2026
A Texas judge blocked the hemp ban. Virginia's governor has until tomorrow. The Medicare CBD hearing lands on 420. And 50,000 people are headed to Denver for it.
Chalk pastel of a shadowy figure behind a frosted glass door with a cannabis leaf shadow
By The Weedcoin Team April 11, 2026
Roger Stone says someone inside the Trump administration is blocking cannabis rescheduling. Spanberger has two days. Massachusetts sent its bill to the governor.
By The Weedcoin Team April 10, 2026
Trump protects medical cannabis in his budget while blocking DC from legalizing. The FBI bans agents from cannabis but allows hemp unless the packaging has a leaf.
Doctor reviewing heart health ECG monitor data with a stethoscope on the desk in a clinic room
By The Weedcoin Team April 9, 2026
A 35-year CARDIA study found no link between cannabis and hypertension. But other major studies show acute cardiovascular risks. Here is the honest full picture.
Young autistic child laughing and building colorful blocks with their father in a sunlit playroom.
By The Weedcoin Team April 8, 2026
A Nature study tracked 82 autistic children on CBD-rich cannabis for six months. Social communication improved on gold-standard assessments. Here is the research.
Empty opioid pill bottles next to cannabis leaves and a recovery journal on a wooden table
By The Weedcoin Team April 7, 2026
New research: states with legal cannabis see a 9-11 point drop in daily opioid use. Over 70% of opioid withdrawal patients report meaningful relief from cannabis.
Elderly man with Parkinson's disease sitting peacefully with his family in a sunlit garden
By The Weedcoin Team April 6, 2026
A new case study shows THC oil reduced Parkinson's motor symptoms by 54.55% in an 83-year-old patient. Here is what the research on cannabis and Parkinson's shows.
Busy cannabis dispensary interior with customers browsing products under warm modern lighting
By The Weedcoin Team April 5, 2026
Legal cannabis revenue projected at $30.5 billion for 2026. Massachusetts fights ballot rollback. DC proposes cannabis-infused drinks. Cannabis skin conditions.
Digital screens displaying red cryptocurrency charts and blockchain data in a darkened trading room
By The Weedcoin Team April 4, 2026
A $280M exploit rattled the Solana ecosystem this week. Cannabis stocks are bleeding under tariff pressure. And CBD is showing real promise for brain injuries.
Elderly woman receiving CBD products from a pharmacist at a pharmacy counter with Medicare forms
By The Weedcoin Team April 3, 2026
A federal judge denied the injunction against Medicare CBD coverage. Trump tariffs are driving up cannabis costs. New Jersey's hemp ban hits in 10 days.
More Posts